Saturday, October 18, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Earnings

Blackbaud Emerges as Quiet Performer in Non-Profit Software Sector

Dieter Jaworski by Dieter Jaworski
August 31, 2025
in Earnings, Insider Trading, Tech & Software
0
Blackbaud Stock
0
SHARES
173
VIEWS
Share on FacebookShare on Twitter

While much of the technology sector faces headwinds, Blackbaud has demonstrated remarkable operational resilience. The provider of software solutions for non-profit organizations didn’t just surpass analyst expectations with its second-quarter results—it also significantly raised its full-year guidance, creating an intriguing contrast with recent insider selling activity.

Strong Quarterly Performance Drives Confidence

The company’s operational metrics tell a compelling story of growth and improved efficiency. Blackbaud reported adjusted earnings per share (EPS) of $1.21, substantially exceeding the consensus estimate of $1.05 by 15 percent. Perhaps more significantly, the company achieved 6.8 percent organic growth after excluding impacts from the divestiture of its EVERFI business. This growth was accompanied by dramatically improved profitability, with the adjusted operating margin expanding by 350 basis points to reach 33.5 percent.

Elevated Guidance and Impressive Metrics

Bolstered by this strong quarterly showing, management has upgraded its outlook for the full year. The company now anticipates 2025 adjusted EPS in the range of $4.30 to $4.50, representing approximately 11 percent growth year-over-year. A particularly noteworthy achievement was the company’s “Rule of 40” score—a key industry metric combining growth rate and profitability margin—which reached a quarterly record of 45.3 percent, highlighting Blackbaud’s effective balance between expansion and financial discipline.

Should investors sell immediately? Or is it worth buying Blackbaud?

Institutional and Insider Activity Presents Mixed Picture

Despite these strong operational results, recent trading activity reveals divergent perspectives among key stakeholders. Director Rupal S. Hollenbeck reduced her position by nearly 24 percent in late July, while Executive Vice President Kevin P. Gregoire sold 8,000 shares. Institutional investors also displayed varied approaches: Northern Trust decreased its holdings, while Mitsubishi UFJ Asset Management and UMB Bank substantially increased their positions in the company.

Analyst Sentiment Remains Cautious

Market experts appear to reflect this uncertainty in their assessments. The consensus price target currently sits between $76 and $79, suggesting significant potential upside from current trading levels. However, analyst recommendations present a divided view: of the six analysts covering the stock, only one maintains a buy recommendation, four suggest holding, and one advises selling.

Adding to the complex investment case, Blackbaud has demonstrated committed capital management through a share repurchase program authorizing buybacks of up to 5 percent of outstanding shares, with $545 million still available under the current authorization. The central question for investors remains whether these strong fundamental results can ultimately overcome the skepticism reflected in recent insider transactions and mixed analyst sentiment.

Ad

Blackbaud Stock: Buy or Sell?! New Blackbaud Analysis from October 18 delivers the answer:

The latest Blackbaud figures speak for themselves: Urgent action needed for Blackbaud investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 18.

Blackbaud: Buy or sell? Read more here...

Tags: Blackbaud
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Intel Stock
Earnings

Intel’s High-Stakes Transformation: Workforce Cuts and Price Hikes Signal Critical Juncture

October 17, 2025
LeonardoADR Stock
Analysis

LeonardoADR Shares Gain Momentum Ahead of Earnings Report

October 17, 2025
Extreme Networks Stock
AI & Quantum Computing

Enterprise Networking Specialist Gains AI-Driven Market Leadership

October 17, 2025
Next Post
PepGen Stock

PepGen Shares Face Mounting Pressure Amid Legal Challenges and Pipeline Shift

Herman Miller Stock

MillerKnoll Navigates Strong Sales and Mounting Headwinds

Cavco Industries Stock

Cavco Industries: The Unseen Leader in Affordable Housing's Surge

Recommended

Formycon Stock

Formycon Stock: Q2 Slump Sparks Investor Skepticism

2 months ago
HIMS stock news

Ohio-based Institutional Investor Strs Ohio Decreases Stake in Hims & Hers Health, Inc.

2 years ago
Finance_ Chart up

Analyst Sarah James Bullish on DocGo with 11 Price Target

2 years ago
Exxon Mobil Stock

Can Exxon Mobil Navigate the Oil Price Downturn?

5 days ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Nike NIO Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Wall Street’s Stark Divide Over UnitedHealth Shares

Political Pressure Mounts as Trump Targets Weight-Loss Drug Pricing

Intel’s High-Stakes Transformation: Workforce Cuts and Price Hikes Signal Critical Juncture

LeonardoADR Shares Gain Momentum Ahead of Earnings Report

Enterprise Networking Specialist Gains AI-Driven Market Leadership

Autoliv’s Q3 2025 Results: A Critical Test for Investors

Trending

Robinhood Stock
Crypto Stocks

Robinhood Shares Experience Dramatic Trading Session

by Dieter Jaworski
October 18, 2025
0

Friday's trading session delivered a rollercoaster performance for Robinhood Markets, with the stock undergoing a remarkable transformation...

Abeona Therapeut. Stock

Biotech Firm Abeona Therapeutics Positioned for Significant Growth

October 18, 2025
Rocket Lab USA Stock

Institutional Investors Flock to Rocket Lab as Space Sector Soars

October 18, 2025
Unitedhealth Stock

Wall Street’s Stark Divide Over UnitedHealth Shares

October 18, 2025
Eli Lilly and Stock

Political Pressure Mounts as Trump Targets Weight-Loss Drug Pricing

October 18, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Robinhood Shares Experience Dramatic Trading Session
  • Biotech Firm Abeona Therapeutics Positioned for Significant Growth
  • Institutional Investors Flock to Rocket Lab as Space Sector Soars

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com